🔬
You have used your free lookups for today
Upgrade to BiotechSigns Pro for unlimited company access, full signal history, watchlist alerts, and 125+ PDUFA dates.
Upgrade to Pro →← Back to screener
← Back to Screener
H

HCM

HUTCHMED China
OncologyScore: 58/100📋 Full Profile
C
58

What is the current HCM catalyst setup?

HCM is tracked by BiotechSigns with a current catalyst score of 58/100 and grade C. The page summarizes 0 active signals, including 0 PDUFA, 0 insider buying, and 0 clinical trial signals, with data refreshed on 2026-06-03.

Analyst Summary
Verified 2026-04-11

HUTCHMED China (HCM) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.

No Form 4 insider filings for HCM were recorded at the SEC in the past 30 days[1].

Sources

  1. SEC EDGAR · 0001648257 (2026-04-11) ↗
Not financial advice. BiotechSigns scores are for informational purposes only and do not constitute investment recommendations. Always do your own due diligence before making investment decisions.
No active signals for HCM
Signal Summary
PDUFA0
Insider0
Clinical0
Data Sources
Dilution◌ LOADING
Sentiment◌ LOADING
SEC EDGAR● LIVE
ClinicalTrials● LIVE
Yahoo Finance● LIVE